ASBP
Aspire Biopharma
ASBP
ASBP
21 hedge funds and large institutions have $18.2M invested in Aspire Biopharma in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
7% more capital invested
Capital invested by funds: $17M → $18.2M (+$1.14M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.39M | |
| 2 | +$925K | |
| 3 | +$902K | |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$542K |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$420K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$1.56M | |
| 3 | -$523K | |
| 4 |
CS
Clear Street
New York
|
-$516K |
| 5 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$182K |